CS logo
small CS logo
David Grant Medical Center

Travis Air Force Base, California, United States
Medical center in Fairfield, California
101 Bodin Cir, Fairfield, CA 94533
230 Beds

About David Grant Medical Center


The David Grant USAF Medical Center at Travis Air Force Base in Fairfield, California, is the U.S. Air Force’s largest medical center in the continental United States and serves military beneficiaries throughout eight western states.
There are 230 beds in David Grant Medical Center.
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at David Grant Medical Center


During the past decade, David Grant Medical Center conducted 19 clinical trials. In the 10-year time frame, 19 clinical trials started and 10 clinical trials were completed, i.e. on average, 52.6% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 5 clinical trials were completed. i.e. 125% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "David Grant Medical Center" #1 sponsor was "SWOG Cancer Research Network" with 53 trials, followed by "Radiation Therapy Oncology Group" with 33 trials sponsored, "Children's Oncology Group" with 20 trials sponsored, "David Grant U.S. Air Force Medical Center" with 19 trials sponsored and "Eastern Cooperative Oncology Group" with 19 trials sponsored. Other sponsors include 14 different institutions and companies that sponsored additional 16 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "David Grant Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 118 trials as a collaborator, "SWOG Cancer Research Network" with 12 trials as a collaborator, "Eastern Cooperative Oncology Group" with 9 trials as a collaborator, "Cancer and Leukemia Group B" with 7 trials as a collaborator and "North Central Cancer Treatment Group" with 6 trials as a collaborator. Other collaborators include 30 different institutions and companies that were collaborators in the rest 29 trials.

Clinical Trials Conditions at David Grant Medical Center


According to Clinical.Site data, the most researched conditions in "David Grant Medical Center" are "Lung Cancer" (18 trials), "Leukemia" (14 trials), "Head and Neck Cancer" (12 trials), "Lymphoma" (12 trials) and "Sarcoma" (10 trials). Many other conditions were trialed in "David Grant Medical Center" in a lesser frequency.

Clinical Trials Intervention Types at David Grant Medical Center


Most popular intervention types in "David Grant Medical Center" are "Drug" (108 trials), "Radiation" (53 trials), "Biological" (32 trials), "Procedure" (27 trials) and "Other" (9 trials). Other intervention types were less common.
The name of intervention was led by "radiation therapy" (44 trials), "filgrastim" (24 trials), "cisplatin" (18 trials), "cyclophosphamide" (18 trials) and "etoposide" (17 trials). Other intervention names were less common.

Clinical Trials Genders at David Grant Medical Center


The vast majority of trials in "David Grant Medical Center" are 129 trials for "All" genders, 16 trials for "Female" genders and 5 trials for "Male" genders.

Clinical Trials Status at David Grant Medical Center


Currently, there are NaN active trials in "David Grant Medical Center". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 125 completed trials in David Grant Medical Center, undefined suspended trials, and 18 terminated clinical trials to date.
Out of the total trials that were conducted in David Grant Medical Center, 11 "Phase 1" clinical trials were conducted, 71 "Phase 2" clinical trials and 43 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 18 trials that are defined as “Not Applicable".